Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Why the focus only on the J3? - dys1

RE: Why the focus only on the J3? - dys1

posted on Mar 11, 2006 06:39PM
I guess that`s one of the things that has me a bit befuddled. The proverbial first nail has already been hammered (i.e., Fujitsu). J4-1. But it does make sense to focus on this because it is the only thing we can wrap our arms around right now - it`s the only thing we KNOW is going on. Everything else (other settlements) is pure speculation (though ultimately a near certainty IMO). According to what the company has advised, future settlements should be for greater and greater amounts (though I suspect the size of the infringement/company would influence).

Now to my favorite object of thought - please stop the dividends and start the share buy-back program! The other benefit to shareholdrs, beyond the ones I`ve mentioned previously, is the fact that WE, the shareholders, could then determine WHEN we want our reward (with the assumption that a reduced float will inherently improve the PPS - beyond the dividend amounts I strongly suspect).

SGE

Share
New Message
Please login to post a reply